Menu Search
Equities

SyntheticMR AB (publ)

SYNT:AKT

SyntheticMR AB (publ)

Actions
  • Price (SEK)10.85
  • Today's Change-0.40 / -3.56%
  • Shares traded3.06k
  • 1 Year change-47.07%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in SEKIncome statement in SEKView more

Year on year SyntheticMR AB (publ) grew revenues 30.67% from 68.27m to 89.21m while net income improved 70.34% from 5.88m to 10.01m.
Gross margin70.27%
Net profit margin5.79%
Operating margin9.54%
Return on assets3.50%
Return on equity4.26%
Return on investment4.24%
More ▼

Cash flow in SEKView more

In 2023, cash reserves at SyntheticMR AB (publ) fell by 19.18m. Cash Flow from Financing was negative, which signals that this company did not need to attract significant financing from outside sources. In addition the company used 6.96m for operations while cash used for investing totalled 9.72m.
Cash flow per share0.2724
Price/Cash flow per share39.86
Book value per share2.72
Tangible book value per share2.14
More ▼

Balance sheet in SEKView more

SyntheticMR AB (publ) uses little debt in its capital structure as supported by a debt to capital ratio of 0.66%.
Current ratio4.28
Quick ratio--
Total debt/total equity0.0066
Total debt/total capital0.0066
More ▼

Growth rates in SEK

Year on year, growth in earnings per share excluding extraordinary items increased 69.03%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
Div yield(5 year avg)0.08%
Div growth rate (5 year)--
Payout ratio (TTM)0.00%
EPS growth(5 years)-7.89
EPS (TTM) vs
TTM 1 year ago		-28.74
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.